机构：[1]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[2]Department of Oncology, The Afliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China
The authors gratefully acknowledge the fnancial support from, the Scientifc
and technological innovation project of China Academy of Chinese Medical
Sciences (CI2023D003, CI2021B014); the CACMS Innovation Fund (CI2023E002,
CI2021A05101 and CI2021A05104); the National Natural Science Foundation
of China (No. 82104480), the Fundamental Research Funds for the Central Public Welfare Research Institutes (Nos. ZZ14-YQ-060, and ZZ16-ND-10-19), and
the Young Elite Scientists Sponsorship Program by CAST (NO.2021-QNRC2-
B29), and Science and Technology Innovation Project of China Academy of
Chinese Medical Sciences (CI2021A04313), the Distinguished Expert Project
of Sichuan Province Tianfu Scholar(CW202002), the Innovation Team and
Talents Cultivation Program of National Administration of Traditional Chinese
Medicine (No: ZYYCXTD-C-202002).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|2 区全科医学与补充医学2 区药学
最新[2023]版：
大类|3 区医学
小类|2 区全科医学与补充医学2 区药学
第一作者：
第一作者机构：[1]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[2]Department of Oncology, The Afliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China
共同第一作者：
通讯作者：
通讯机构：[1]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[2]Department of Oncology, The Afliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China
推荐引用方式(GB/T 7714)：
Lu Tianming,Zhou Lirun,Chu Zheng,et al.Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway[J].Chinese Medicine.2024,19(1):54.doi:10.1186/s13020-024-00895-0.
APA：
Lu Tianming,Zhou Lirun,Chu Zheng,Song Yang,Wang Qixin...&Guo Qiuyan.(2024).Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway.Chinese Medicine,19,(1)
MLA：
Lu Tianming,et al."Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway".Chinese Medicine 19..1(2024):54
